Show simple item record

dc.contributor.authorRueda Espinel, Santiago
dc.coverage.spatialBucaramanga (Santander, Colombia)spa
dc.coverage.temporal2021spa
dc.date.accessioned2023-06-28T23:11:34Z
dc.date.available2023-06-28T23:11:34Z
dc.date.issued2021-11
dc.identifier.issnISSN 2344-7079spa
dc.identifier.urihttp://hdl.handle.net/20.500.12749/20369
dc.description.abstractEn éste documento se detallan las indicaciones básicas a seguir para la presentación de trabajos de investigación al XII Encuentro de Semilleros de Investigación “El Intercambio del Conocimiento: Base para el Desarrollo”spa
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.relation.ispartofseriesGeneración Creativa : Encuentro de Semilleros de Investigación UNABspa
dc.relation.urihttp://hdl.handle.net/20.500.12749/20335spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.sourceRueda, S. (2021). Factores asociados al éxito del manejo médico con misoprostol en el aborto espontáneo: una cohorte prospectiva. Recuperado de: http://hdl.handle.net/20.500.12749/20369.spa
dc.titleFactores asociados al éxito del manejo médico con misoprostol en el aborto espontáneo: una cohorte prospectivaspa
dc.typeConferenceeng
dc.title.translatedFactors associated with the success of medical management with misoprostol in spontaneous abortion: a prospective cohortspa
dc.publisher.grantorUniversidad Autónoma de Bucaramanga UNABspa
dc.rights.localAbierto (Texto Completo)spa
dc.publisher.facultyFacultad Ciencias de la Saludspa
dc.type.driverinfo:eu-repo/semantics/conferenceProceedingsspa
dc.type.localMemoria de eventosspa
dc.type.coarhttp://purl.org/coar/resource_type/c_f744
dc.subject.keywordsGynecologyspa
dc.subject.keywordsObstetricsspa
dc.subject.keywordsAbortionspa
dc.subject.keywordsInvestigationspa
dc.subject.keywordsMisoprostolspa
dc.subject.keywordsMaternal mortalityspa
dc.subject.keywordsPregnancyspa
dc.subject.keywordsWomenspa
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga - UNABspa
dc.identifier.reponamereponame:Repositorio Institucional UNABspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.relation.references[1] Peña García MJ. Guía de Práctica Clínica (GPC) para el manejo médico del aborto en el Hospital Local del Norte - E.S.E ISABU. 2018;spa
dc.relation.references[2] Organización Mundial de la Salud. Mortalidad materna. 2018;Nota descriptiva No. 348.spa
dc.relation.references[3] Sur SD, Raine-Fenning NJ. The management of miscarriage. Best Pract Res Clin Obstet Gynaecol. Elsevier Ltd. 2009;23(4):479–91.spa
dc.relation.references[4] Blum J, Winikoff B, Gemzell-Danielsson K, Ho PC, Schiavon R, Weeks A. Treatment of incomplete abortion and miscarriage with misoprostol. Int J Gynecol Obstet. 2007;99:186–9.spa
dc.relation.references[5] Creinin MD, Barnhart K, Zhang J, Gilles JM, Westhoff C, Huang X. Factors Related to Successful Misoprostol Treatment for Early Pregnancy Failure. Obstet Gynecol. 2006;107(4):901–7.spa
dc.relation.references[6] Barceló F, De Paco C, López-Espín JJ, Silva Y, Abad L, Parrilla JJ. The management of missed miscarriage in an outpatient setting: 800 versus 600 μg of vaginal misoprostol. Aust New Zeal J Obstet Gynaecol. 2012;52(1):39–43.spa
dc.relation.references[7] Committee on Practice Bulletins—Gynecology. Early Pregnancy Loss. Am Coll Obstet Gynecol [Internet]. 2015; number 150. Available from: https://www.acog.org/Clinical-Guidance-and-Publications/Practice- Bulletins/Committee-on-Practice-Bulletins-Gynecology/Early-Pregnancy-Lossspa
dc.relation.references[8] Hasan R, Baird DD, Herring AH, Olshan AF, Jonsson Funk ML, Hartmann KE. Association between first- trimester vaginal bleeding and miscarriage. Obstet Gynecol. 2009;114(4):860–7.spa
dc.relation.references[9] Faúndes A, Fiala C, Tang OS, Velasco A. Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy. Int J Gynecol Obstet. 2007;99:172–7.spa
dc.relation.references[10] Bagratee JS, Khullar V, Regan L, Moodley J, Kagoro H. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Hum Reprod. 2004;19(2):266–71.spa
dc.relation.references[11] INVIMA. Mifepristona [Internet]. Expediente 20104433. 2016. Available from: http://consultaregistro.invima.gov.co:8082/Consultas/consultas/consreg_encabcum.jspspa
dc.relation.references[12] von Hertzen H, Piaggio G, Huong NTM, Arustamyan K, Cabezas E, Gomez M, et al. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial. Lancet. 2007;369(9577):1938–46.spa
dc.relation.references[13] Tang OS, Ho PC. The pharmacokinetics and different regimens of misoprostol in early first-trimester medical abortion. Contraception. 2006;74(1):26–30.spa
dc.relation.references[14] Committee on Practice Bulletins—Gynecology and the Society of Family Planning. Medical management of first-trimester abortion. Am Coll Obstet Gynecol. 2014;89(3):148–161.spa
dc.relation.references[15] Tang J, Kapp N, Dragoman M, De Souza JP. WHO recommendations for misoprostol use for obstetric and gynecologic indications. Int J Gynecol Obstet [Internet]. 2013;121(2):186–9. Available from: http://dx.doi.org/10.1016/j.ijgo.2012.12.009spa
dc.relation.references[16] Jp N, Gml G, Hickey M, Jc V, Dou L. Medical treatments for incomplete miscarriage (Review). Cochrane Libr. 2013;(3).spa
dc.relation.references[17] Gómez-Sánchez P. Manual FLASOG uso Misoprostol en Ginecoobstetricia. 2013.spa
dc.relation.references[18] INVIMA. Acta 20, Radicado 7023192. Minist Salud y Protección Soc. 2007.spa
dc.relation.references[19] Corte Constitucional. Sentencia C-355/06 [Internet]. República de Colombia. 2006. Available from: http://www.corteconstitucional.gov.co/relatoria/2006/c-355-06.htmspa
dc.relation.references[20] INVIMA. Decreto No. 4444. 2005.spa
dc.relation.references[21] Colombia Ministerio de la Protección Social. Resolución 4905 [Internet]. 2006. Available from: https://www.minsalud.gov.co/Normatividad_Nuevo/Resolución 4905 de 2006.PDFspa
dc.relation.references[22] Blanchard K, Shochet T, Coyaji K, Nguyen Thi NN, Winikoff B. Misoprostol alone for early abortion: An evaluation of seven potential regimens. Contraception. 2005;72(2):91–7.spa
dc.relation.references[23] Gemzell-Danielsson K, Bygdeman M, Aronsson A. Studies on uterine contractility following mifepristone and various routes of misoprostol. Contraception. 2006;74(1):31–5.spa
dc.relation.references[24] Gemzell-Danielsson, L Marions, A Rodriguez, BW Spur, PYK Wong MB. Comparison Between Oral and Vaginal Administration of Misoprostol on Uterine Contractility. Am Coll Obstet Gynecol Elsevier. 1999;93(2):275–80.spa
dc.relation.references[25] Granstrom G, Granstrom M, Anderson M. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone mifepristone and an exogenous prostaglandin given. Lancet. 1991;338:1233–6.spa
dc.relation.references[26] Odeh M, Tendler R, Kais M, Maximovsky O, Ophir E, Bornstein J. Early pregnancy failure: Factors affecting successful medical treatment. Isr Med Assoc J. 2010;12(6):325–8.spa
dc.relation.references[27] Fiala C, Cameron S, Bombas T, Parachini M, Agostini A, Lertxundi R, et al. Outcome of first trimester medical termination of pregnancy: definitions and management. Eur J Contracept Reprod Heal Care [Internet]. 2018;23(6):451–7. Available from: https://doi.org/10.1080/13625187.2018.1535058spa
dc.relation.references[28] Chung T, Leung P, Cheung L, Haines C, Chang A. A medical approach to management of spontaneous abortion using misoprostol. Acta Obstet Gynecol Scand. 1997;76:248–51.spa
dc.relation.references[29] Cheung LP, Haines CJ, Chang AMZ. Spontaneous abortion: a randomized, controlled trial comparing surgical evacuation with conservative management using misoprostol. Fertil Steril. 1999;71(6):1054–9.spa
dc.relation.references[30] Creinin MD, Chen MJ. Medical abortion reporting of efficacy: the MARE guidelines. Contraception [Internet]. 2016;94(2):97–103. Available from: http://dx.doi.org/10.1016/j.contraception.2016.04.013spa
dc.relation.references[31] Morris JL, Winikoff B, Dabash R, Weeks A, Faundes A, Gemzell-Danielsson K, et al. FIGO’s updated recommendations for misoprostol used alone in gynecology and obstetrics. Int J Gynecol Obstet. 2017;138(3):363–6.spa
dc.relation.references[32] Berghella V, Airoldi J, O’Neill A, Einhorn K, Hoffman M. Misoprostol for second trimester pregnancy termination in women with prior caesarean: A systematic review. BJOG An Int J Obstet Gynaecol. 2009;116(9):1151–7.spa
dc.relation.references[33] Goyal V. Uterine rupture in second-trimester misoprostol-induced abortion after cesarean delivery: A systematic review. Am Coll Obstet Gynecol. 2009;113(5):1117–23.spa
dc.relation.references[34] Chen BA, Reeves MF, Creinin MD, Gilles JM, Barnhart K, Westhoff C, et al. Misoprostol for treatment of early pregnancy failure in women with previous uterine surgery. Am J Obstet Gynecol. 2008;198(6):626.e1-626.e5.spa
dc.relation.references[35] Memtsa M, Jauniaux E, Gulbis B, Nyrhinen NC, Jurkovic D. Maternal serum markers in predicting successful outcome in expectant management of missed miscarriage. Reprod Biomed Online, Elsevier [Internet]. 2017;34(1):98–103. Available from: http://dx.doi.org/10.1016/j.rbmo.2016.09.004spa
dc.contributor.cvlacRueda Espinel, Santiago [0000037531]spa
dc.contributor.orcidRueda Espinel, Santiago [0000-0003-2156-166X]spa
dc.subject.lembGinecologíaspa
dc.subject.lembObstetriciaspa
dc.subject.lembAbortospa
dc.subject.lembInvestigaciónspa
dc.identifier.repourlrepourl:https://repository.unab.edu.cospa
dc.description.abstractenglishIn this paper, we describe the formatting guidelines for the XII Encuentro de Semilleros de Investigación “El Intercambio del Conocimiento: Base para el Desarrollo". The abstract most be written in english.spa
dc.subject.proposalMisoprostolspa
dc.subject.proposalMortalidad maternaspa
dc.subject.proposalEmbarazospa
dc.subject.proposalMujeresspa
dc.type.redcolhttp://purl.org/redcol/resource_type/EC_AC
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.publisher.deparmentSistema de Investigación SIUNABspa
dc.contributor.researchgroupSemilleros de Investigación UNABspa
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.coverage.campusUNAB Campus Bucaramangaspa
dc.description.learningmodalityModalidad Presencialspa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 2.5 Colombia
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 2.5 Colombia